ASX-listed healthcare technology company, InteliCare has shown it is capable of scaling up after posting first-half customer revenues of $235,518 against revenues of just $9,497 for the previous corresponding quarter. The company also banked an additional $553,813 on the top line for the December 2020 half, largely from an R&D tax offset grant and Government COVID-19 grant payments.